Komokata Teruo, Nishida Seigo, Ganz Susan, Suzuki Tomomi, Olson Les, Tzakis Andreas G
Second Department of Surgery, Kagoshima University School of Medicine, Kagoshima, Japan.
Transplantation. 2003 Aug 27;76(4):705-8. doi: 10.1097/01.TP.0000079916.07254.3D.
To overcome the critical shortage of liver grafts, many centers have been widening the acceptance criteria for liver donation. Use of liver grafts from victims who have suffered chemical overdose (COD) may be one option that could help to expand the donor pool. However, this practice has been poorly documented.
Of 1,195 orthotopic liver transplantations performed at our institution between June 1994 and March 2001, 22 involved livers (1.8%) were retrieved from COD donors. Donor and recipient characteristics and posttransplantation outcomes were analyzed retrospectively.
The main chemicals causing brain death of the donor were carbon monoxide (n=4), cocaine (n=4), tricyclic antidepressants (n=3), 3,4-methylenedioxy- methamphetamine (n=2), opiates (n=2), aspirin (n=1), gamma hydroxybutyrate (n=1), heroin (n=1), insulin (n=1), verapamil (n=1), barbiturate (n=1), and brompheniramine/phenylpropanolamine (n=1). Primary nonfunction developed in one patient who had received a liver from an 3,4-methylenedioxymethamphetamine-intoxicated donor. Another patient died of fungal meningitis 10 days after transplantation with a functioning graft. The remaining 20 patients experienced acceptable early graft function, as demonstrated by initial mean peak values of bilirubin (4.8 mg/dL), aspartate aminotransferase (624 U/L), and alanine aminotransferase (730 U/L). One-year graft survival rate estimated by the Kaplan-Meier method was 86%.
Satisfactory outcomes of graft function were achieved in orthotopic liver transplantations from COD donors. The cautious use of liver grafts from selected COD donors may be a worthwhile method of increasing the availability of scarce donor organs.
为克服肝移植供体严重短缺的问题,许多中心一直在放宽肝捐赠的接受标准。使用化学药物过量(COD)受害者的肝脏移植物可能是有助于扩大供体库的一种选择。然而,这种做法的记录很少。
在1994年6月至2001年3月期间,我们机构进行的1195例原位肝移植中,有22例(1.8%)肝脏是从COD供体获取的。对供体和受体特征以及移植后结果进行回顾性分析。
导致供体脑死亡的主要化学物质有一氧化碳(n = 4)、可卡因(n = 4)、三环类抗抑郁药(n = 3)、3,4 - 亚甲基二氧甲基苯丙胺(n = 2)、阿片类药物(n = 2)、阿司匹林(n = 1)、γ - 羟基丁酸(n = 1)、海洛因(n = 1)、胰岛素(n = 1)、维拉帕米(n = 1)、巴比妥酸盐(n = 1)以及溴苯那敏/苯丙醇胺(n = 1)。一名接受了3,4 - 亚甲基二氧甲基苯丙胺中毒供体肝脏的患者发生了原发性无功能。另一名患者在移植后10天因真菌性脑膜炎死亡,其移植物功能良好。其余20例患者早期移植物功能可接受,胆红素初始平均峰值为4.8mg/dL,天冬氨酸转氨酶为624U/L,丙氨酸转氨酶为730U/L。采用Kaplan - Meier法估计的1年移植物存活率为86%。
从COD供体进行原位肝移植可获得令人满意的移植物功能结果。谨慎使用选定的COD供体的肝脏移植物可能是增加稀缺供体器官可用性的一种值得尝试的方法。